MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Debt to Asset Ratio
11.92%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Property and equipment, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
12,996
17,031
21,031
10,705
Prepaid expenses and other current assets
1,302
371
445
788
Total current assets
14,298
17,402
21,476
11,493
Property, plant and equipment, gross
-
-
239
-
Less accumulated depreciation and amortization
-
-
228
-
Property and equipment, net
9
10
11
12
Total assets
14,307
17,412
21,487
11,505
Accounts payable
901
260
435
516
Accrued expenses
804
690
905
1,150
Total liabilities
1,705
950
1,340
1,666
Common stock, 0.0001 par value, 100,000,000 shares authorized 11,617,250 and 11,617,250 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
1
1
1
Additional paid-in capital
175,796
175,518
175,200
162,521
Accumulated deficit
-163,195
-159,057
-155,054
-152,683
Total stockholders' equity
12,602
16,462
20,147
9,839
Total liabilities and stockholders' equity
14,307
17,412
21,487
11,505
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$12,996K (20.61%↑ Y/Y)Prepaid expenses andother current assets$1,302K (150.87%↑ Y/Y)Total current assets$14,298K (26.60%↑ Y/Y)Property and equipment,net$9K (28.57%↑ Y/Y)Total assets$14,307K (26.60%↑ Y/Y)Total liabilities andstockholders' equity$14,307K (26.60%↑ Y/Y)Total stockholders'equity$12,602K (24.83%↑ Y/Y)Total liabilities$1,705K (41.38%↑ Y/Y)Accumulated deficit-$163,195K (-8.59%↓ Y/Y)Additional paid-in capital$175,796K (9.61%↑ Y/Y)Accounts payable$901K (283.40%↑ Y/Y)Accrued expenses$804K (-17.20%↓ Y/Y)Common stock, 0.0001par value,...$1K

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp. (PHIO)